Results
24
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
24 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €5.52 | 0.7% | -48.3% | €83.0m | €6.30 | PS13.7x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €11.76 | -0.7% | -37.4% | €97.2m | €20.75 | PE12.9x | E36.0% | n/a | Capital Goods | ||
VU | €146.80 | 3.6% | 18.8% | €2.4b | €193.33 | PE29.5x | E25.7% | 0.2% | Tech | ||
OSE | €7.20 | -11.7% | 15.4% | €156.6m | €13.50 | PS70.3x | E5.9% | n/a | Pharmaceuticals & Biotech | ||
FDE | €26.90 | -0.4% | -37.3% | €142.0m | €60.33 | PE18.1x | E31.9% | n/a | Energy | ||
ALMUN | €0.41 | 0% | -80.3% | €3.7m | €1.30 | PB0.3x | E149.1% | n/a | Tech | ||
ALCUR | €5.84 | -3.3% | 143.3% | €33.7m | €8.48 | PE18.7x | E27.5% | n/a | Capital Goods | ||
ALICA | €9.62 | -2.8% | -30.3% | €77.8m | €15.00 | PE14.2x | E27.3% | 2.1% | Tech | ||
MEDCL | €16.20 | -12.0% | 131.4% | €471.2m | €22.03 | PS39.4x | E93.9% | n/a | Pharmaceuticals & Biotech | ||
ALSMA | €4.07 | 2.3% | 56.5% | €21.2m | €5.80 | PE20.1x | E35.2% | n/a | Healthcare | ||
ALSTI | €17.85 | -3.3% | n/a | €90.8m | €16.50 | PE45.4x | E28.5% | 1.1% | Capital Goods | ||
ALLIX | €8.95 | 8.0% | -10.0% | €58.7m | €13.50 | PS1.8x | E102.1% | n/a | Software | ||
ALECP | €0.56 | -19.2% | -16.8% | €69.4m | n/a | PE77.1x | E86.8% | 0% | Media | ||
ALVGO | €3.08 | -0.6% | -18.9% | €18.8m | €4.40 | PS1.5x | E77.2% | n/a | Software | ||
ALCIS | €8.20 | -6.0% | -11.4% | €63.8m | €12.10 | PE20x | E56.5% | 2.0% | Commercial Services | ||
ALHOP | €22.30 | -2.6% | 41.1% | €64.0m | €30.40 | PE14x | E22.3% | 2.9% | Media | ||
LSS | €28.50 | 3.3% | 4.2% | €1.1b | €34.58 | PE33.8x | E29.3% | 1.3% | Software | ||
OVH | €6.10 | 6.6% | -33.2% | €1.2b | €9.35 | PS1.2x | E101.1% | n/a | Software | ||
GUI | €5.14 | -3.0% | -24.0% | €77.3m | €7.85 | PE80.1x | E55.0% | 0% | Tech | ||
CLA | €1.39 | -3.7% | -19.9% | €78.8m | €4.65 | PE-15.8x | E88.7% | n/a | Software | ||
ALPAT | €15.50 | -2.5% | 30.3% | €17.2m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
S30 | €1.47 | -4.0% | -43.5% | €157.8m | €2.17 | PB1.4x | E100.6% | n/a | Software | ||
ALBLD | €15.20 | -8.7% | -3.3% | €69.1m | €21.43 | PE24.7x | E30.5% | n/a | Media | ||
EXN | €23.50 | 0.4% | 26.3% | €2.1b | €25.33 | PE51.9x | E33.7% | 0% | Software |